{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:30:12Z","timestamp":1790130612673,"version":"4.0.1"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100004954","name":"Augustinus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004954","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF23OC0081668"],"award-info":[{"award-number":["NNF23OC0081668"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Infections from immunosuppressive treatment are a major cause of hospitalization and mortality in ANCA-associated vasculitis (AAV). This study examines bloodstream infections (BSIs) in incident AAV patients, comparing incidence, bacterial distribution and risk to the general population, with emphasis on central venous catheters (CVCs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using Danish nationwide registries, we studied patients diagnosed from 2010 to 2018, followed until first BSI, death or a maximum of 5\u2009years. Controls were matched 1:4 by age and sex. Cumulative incidence was estimated using Aalen\u2013Johansen, and adjusted Cox regression modelled survival time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 111 BSIs were identified in 80 (8.5%) of 937 AAV patients, compared with 65 BSIs in 58 (1.7%) of 3476 controls. The incidence of BSIs was significantly higher in AAV patients (34.5\/1000 person-years against 4.8\/1000 person-years). One-year hazard ratio (HR) for first-time BSIs was significantly elevated in AAV patients (HR 10.5, [95% CI 5.58\u201311.9]), and those receiving haemodialysis (HR 34.8, 95% CI 3.35\u2013360.8) or plasma exchange (HR 14.6, 95% CI 3.79\u201356.6) faced even higher infection rates. Following first-time BSI, one-year mortality rates were equally high in AAV patients (36.3%) and controls (34.5%). Most common microbial agents\u2014Escherichia coli, Staphylococcus aureus, enterococci and streptococci\u2014were similar between the two groups. However, AAV patients exhibited higher microbial diversity, with 48.6% attributed to other pathogens like coagulase-negative staphylococci, Klebsiella pneumoniae, Pseudomonas aeruginosa and fungi.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>AAV patients face high BSI risk, diverse microbiology and increased one-year mortality, with CVC-related interventions as solitary risk factors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaf438","type":"journal-article","created":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T11:31:04Z","timestamp":1755343864000},"page":"6328-6336","source":"Crossref","is-referenced-by-count":1,"title":["High risk of bloodstream infections, diverse causal pathogens and association with haemodialysis and plasma exchange in ANCA-associated vasculitis"],"prefix":"10.1093","volume":"64","author":[{"given":"Nanna Thuesen","family":"Bruun","sequence":"first","affiliation":[{"name":"Department of Nephrology, Copenhagen University Hospital\u2014Rigshospitalet , Copenhagen,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dea H","family":"Kofod","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Copenhagen University Hospital\u2014Rigshospitalet , Copenhagen,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Carlson","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Copenhagen University Hospital\u2014Rigshospitalet , Copenhagen,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0123-4007","authenticated-orcid":false,"given":"Mads","family":"Hornum","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Copenhagen University Hospital\u2014Rigshospitalet , Copenhagen,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , Copenhagen,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil L","family":"Fosb\u00f8l","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , Copenhagen,","place":["Denmark"]},{"name":"Department of Cardiology, Heart Centre, Copenhagen University Hospital\u2014Rigshospitalet , Copenhagen,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3298-1467","authenticated-orcid":false,"given":"Lauge","family":"\u00d8stergaard","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Heart Centre, Copenhagen University Hospital\u2014Rigshospitalet , Copenhagen,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Volstedlund","sequence":"additional","affiliation":[{"name":"Department of Data Integration and Analysis, Statens Serum Institut , Copenhagen,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stine H","family":"Finsen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Odense University Hospital , Odense,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7664-8570","authenticated-orcid":false,"given":"Claus","family":"Moser","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Copenhagen University Hospital\u2014Rigshospitalet , Copenhagen,","place":["Denmark"]},{"name":"Department of Immunology and Microbiology, Copenhagen University , Copenhagen,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casper","family":"Rydahl","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine, Copenhagen University Hospital\u2014Herlev and Gentofte , Herlev,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Ivarsen","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine, Aarhus University Hospital , Aarhus,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Aarhus University Hospital , Aarhus,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon Waarst","family":"Gregersen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Aalborg University Hospital , Aalborg,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Egfjord","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Copenhagen University Hospital\u2014Rigshospitalet , Copenhagen,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , Copenhagen,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6570-6077","authenticated-orcid":false,"given":"Wladimir M","family":"Szpirt","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Copenhagen University Hospital\u2014Rigshospitalet , Copenhagen,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl Emil","family":"Nelveg-Kristensen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Copenhagen University Hospital\u2014Rigshospitalet , Copenhagen,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Danish Vasculitis Association (DANVAS)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten Buus","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilie","family":"Lyngs\u00f8e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Dieperink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Nygaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"key":"2025120216032240000_keaf438-B1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejim.2020.01.011","article-title":"ANCA associated vasculitis","volume":"74","author":"Salvador","year":"2020","journal-title":"Eur J Intern Med"},{"key":"2025120216032240000_keaf438-B2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.autrev.2012.08.006","article-title":"Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis","volume":"12","author":"Sinico","year":"2013","journal-title":"Autoimmun Rev"},{"key":"2025120216032240000_keaf438-B3","first-page":"683","author":"Kronbichler"},{"key":"2025120216032240000_keaf438-B4","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1093\/rheumatology\/kez589","article-title":"All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type","volume":"59","author":"Wallace","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2025120216032240000_keaf438-B5","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/ard.2010.137778","article-title":"Long-term patient survival in ANCA-associated vasculitis","volume":"70","author":"Flossmann","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2025120216032240000_keaf438-B6","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/eci.12410","article-title":"Frequency, risk factors and prophylaxis of infection in ANCA-associated vasculitis","volume":"45","author":"Kronbichler","year":"2015","journal-title":"Eur J Clin Invest"},{"key":"2025120216032240000_keaf438-B7","doi-asserted-by":"crossref","first-page":"iii74","DOI":"10.1093\/rheumatology\/kez618","article-title":"Complications of therapy for ANCA-associated vasculitis","volume":"59","author":"Smith","year":"2020","journal-title":"Rheumatol (Oxford)"},{"key":"2025120216032240000_keaf438-B8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"2025120216032240000_keaf438-B9","first-page":"263","article-title":"The Danish National Hospital Register. A valuable source of data for modern health sciences","volume":"46","author":"Andersen","year":"1999","journal-title":"Dan Med Bull"},{"key":"2025120216032240000_keaf438-B10","first-page":"445","article-title":"The Danish prescription registries","volume":"44","author":"Gaist","year":"1997","journal-title":"Dan Med Bull"},{"key":"2025120216032240000_keaf438-B11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1403494811399958","article-title":"The Danish Register of causes of death","volume":"39","author":"Helweg-Larsen","year":"2011","journal-title":"Scand J Public Health"},{"key":"2025120216032240000_keaf438-B12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/ndt\/gfaa303","article-title":"Increasing incidence and improved survival in ANCA-associated vasculitis\u2014a Danish nationwide study","volume":"37","author":"Nelveg-Kristensen","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"2025120216032240000_keaf438-B13","doi-asserted-by":"crossref","first-page":"20667","DOI":"10.2807\/1560-7917.ES2014.19.1.20667","article-title":"The Danish Microbiology Database (MiBa) 2010 to 2013","volume":"19","author":"Voldstedlund","year":"2014","journal-title":"Euro Surveill"},{"key":"2025120216032240000_keaf438-B14","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.ejheart.2008.05.006","article-title":"Accuracy of a heart failure diagnosis in administrative registers","volume":"10","author":"K\u00fcmler","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"2025120216032240000_keaf438-B15","doi-asserted-by":"crossref","first-page":"d124","DOI":"10.1136\/bmj.d124","article-title":"Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study","volume":"342","author":"Olesen","year":"2011","journal-title":"BMJ"},{"key":"2025120216032240000_keaf438-B16","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/ard.2009.109389","article-title":"Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis","volume":"69","author":"Little","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2025120216032240000_keaf438-B17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3899\/jrheum.190065","article-title":"Prevalence and risk factors for major infections in patients with antineutrophil cytoplasmic antibody-associated vasculitis: influence on the disease outcome","volume":"47","author":"Garcia-Vives","year":"2020","journal-title":"J Rheumatol"},{"key":"2025120216032240000_keaf438-B18","doi-asserted-by":"crossref","first-page":"105768","DOI":"10.1016\/j.jbspin.2024.105768","article-title":"Update on targeted treatments for ANCA-associated vasculitis","volume":"92","author":"Pu\u00e9chal","year":"2025","journal-title":"Joint Bone Spine"},{"key":"2025120216032240000_keaf438-B19","doi-asserted-by":"crossref","first-page":"e064604","DOI":"10.1136\/bmj-2021-064604","article-title":"The effects of plasma exchange in patients with ANCA-Associated vasculitis: an updated systematic review and meta-analysis","volume":"376","author":"Walsh","year":"2022","journal-title":"BMJ"},{"key":"2025120216032240000_keaf438-B20","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1164\/rccm.202308-1426OC","article-title":"Alveolar hemorrhage in antineutrophil cytoplasmic antibody-associated vasculitis: results of an international randomized controlled trial (PEXIVAS)","volume":"209","author":"Fussner","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2025120216032240000_keaf438-B21","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1007\/s00393-016-0067-5","article-title":"[Therapy of ANCA-associated vasculitis with severe renal manifestation under routine conditions]","volume":"75","author":"Stille","year":"2016","journal-title":"Z Rheumatol"},{"key":"2025120216032240000_keaf438-B22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13075-021-02452-8","article-title":"Serious infections in ANCA-associated vasculitides in the biologic era: real-life data from a multicenter cohort of 162 patients","volume":"23","author":"Thomas","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"2025120216032240000_keaf438-B23","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1093\/rheumatology\/kez575","article-title":"Predictive factors of severe infections in patients with systemic necrotizing vasculitides: data from 733 patients enrolled in five randomized controlled trials of the French Vasculitis Study Group","volume":"59","author":"Lafarge","year":"2020","journal-title":"Rheumatology"},{"key":"2025120216032240000_keaf438-B24","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.3899\/jrheum.160909","article-title":"Severe infection in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"44","author":"Mohammad","year":"2017","journal-title":"J Rheumatol"},{"key":"2025120216032240000_keaf438-B25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12882-018-0933-2","article-title":"Risk factors for infectious complications of ANCA-associated vasculitis: a cohort study","volume":"19","author":"Yang","year":"2018","journal-title":"BMC Nephrol"},{"key":"2025120216032240000_keaf438-B26","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1093\/rheumatology\/keaa699","article-title":"Incidence and predictors of severe infections in ANCA-associated vasculitis: a population-based cohort study","volume":"60","author":"Rathmann","year":"2021","journal-title":"Rheumatology (Ocford)"},{"key":"2025120216032240000_keaf438-B27","first-page":"66","article-title":"Incidence and clinical predictors of infections in patients treated with severe systemic ANCA-associated vasculitis","volume":"108","author":"Haris","year":"2021","journal-title":"Physiol Int"},{"key":"2025120216032240000_keaf438-B28","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1186\/s12879-018-3594-7","article-title":"Risk of death after first-time blood stream infection in incident dialysis patients with specific consideration on vascular access and comorbidity","volume":"18","author":"Nelveg-Kristensen","year":"2018","journal-title":"BMC Infect Dis"},{"key":"2025120216032240000_keaf438-B29","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.ajkd.2019.12.001","article-title":"KDOQI clinical practice guideline for vascular access: 2019 update","volume":"75","author":"Lok","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"2025120216032240000_keaf438-B30","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1093\/cid\/cir257","article-title":"Guidelines for the prevention of intravascular catheter-related infections","volume":"52","author":"O'Grady","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2025120216032240000_keaf438-B31","doi-asserted-by":"crossref","first-page":"e26733","DOI":"10.1097\/MD.0000000000026733","article-title":"Cyclophosphamide induction dose and outcomes in ANCA-associated vasculitis with renal involvement: a comparative cohort study","volume":"100","author":"Speer","year":"2021","journal-title":"Medicine"},{"key":"2025120216032240000_keaf438-B32","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1007\/s10067-023-06644-2","article-title":"Outcomes of remission induction therapy for ANCA-associated vasculitis in the elderly","volume":"42","author":"Aqeel","year":"2023","journal-title":"Clin Rheumatol"},{"key":"2025120216032240000_keaf438-B33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.semarthrit.2015.02.005","article-title":"Rituximab for remission induction in elderly patients with ANCA-associated vasculitis","volume":"45","author":"Timlin","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"2025120216032240000_keaf438-B34","doi-asserted-by":"crossref","first-page":"945011","DOI":"10.3389\/fmed.2022.945011","article-title":"Relationship between gender and 1-year mortality in ANCA-associated vasculitis patients: a single-center retrospective analysis and meta-analysis","volume":"9","author":"Zhu","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"2025120216032240000_keaf438-B35","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1136\/annrheumdis-2015-208073","article-title":"Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type","volume":"75","author":"Unizony","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2025120216032240000_keaf438-B36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00296-024-05757-4","article-title":"Remission induction therapies and long-term outcomes in granulomatosis with polyangiitis and microscopic polyangiitis: real-world data from a European cohort","volume":"45","author":"Kr\u00e4mer","year":"2024","journal-title":"Rheumatol Int"},{"key":"2025120216032240000_keaf438-B37","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJMoa1108735","article-title":"Genetically distinct subsets within ANCA-associated vasculitis","volume":"367","author":"Lyons","year":"2012","journal-title":"N Engl J Med"},{"key":"2025120216032240000_keaf438-B38","doi-asserted-by":"crossref","first-page":"803175","DOI":"10.3389\/fimmu.2021.803175","article-title":"A personalized rituximab retreatment approach based on clinical and B-cell biomarkers in ANCA-associated vasculitis","volume":"12","author":"Arnold","year":"2021","journal-title":"Front Immunol"},{"key":"2025120216032240000_keaf438-B39","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.3389\/fimmu.2019.02855","article-title":"Personalized medicine in ANCA-associated vasculitis ANCA specificity as the guide?","volume":"10","author":"Wallace","year":"2019","journal-title":"Front Immunol"},{"key":"2025120216032240000_keaf438-B40","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1093\/rheumatology\/kex367","article-title":"Towards precision medicine in ANCA-associated vasculitis","volume":"57","author":"van der Geest","year":"2018","journal-title":"Rheumatology"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaf438\/64084992\/keaf438.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/12\/6328\/64084992\/keaf438.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/12\/6328\/64084992\/keaf438.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T21:03:35Z","timestamp":1764709415000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/12\/6328\/8238178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":40,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,8,19]]},"published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaf438","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,8,19]]}}}